Inogen, Inc. (INGN)
NMS · Healthcare · Medical Devices
Closing price as of 2026-09-11 · Source: TEK2day Finance
Key Metrics
About Inogen, Inc.
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.
Quarterly Financials
| Metric | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 92.4M | 81.7M | 85.1M | 95.1M |
| Gross Profit | 41.3M | 35.2M | 37.9M | 43.3M |
| Operating Income | (7.1M) | (9.3M) | (9.3M) | (5.1M) |
| Net Income | (5.3M) | (7.1M) | (8.3M) | (3.9M) |
| Diluted EPS | $-0.20 | $-0.26 | $-0.30 | $-0.14 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 377.2M | 315.7M | 335.7M | 348.7M |
| Gross Profit | 153.5M | 126.7M | 154.7M | 154.3M |
| Operating Income | (33.1M) | (76.5M) | (42.5M) | (30.2M) |
| Net Income | (83.8M) | (102.4M) | (35.9M) | (22.7M) |
| Diluted EPS | $-3.67 | $-4.42 | $-1.52 | $-0.86 |